APA (7th ed.) Citation

Kappos, L., Comi, G., Palace, J., Siever, A., Marrosu, M., Mehling, M., . . . Gold, R. (2012). Safety and tolerability of fingolimod 0.5 mg during the first 4 months of administration in patients with relapsing forms of multiple sclerosis. Results from the open-label, multicentre FIRST study.

Chicago Style (17th ed.) Citation

Kappos, L., et al. Safety and Tolerability of Fingolimod 0.5 Mg During the First 4 Months of Administration in Patients with Relapsing Forms of Multiple Sclerosis. Results from the Open-label, Multicentre FIRST Study. 2012.

MLA (9th ed.) Citation

Kappos, L., et al. Safety and Tolerability of Fingolimod 0.5 Mg During the First 4 Months of Administration in Patients with Relapsing Forms of Multiple Sclerosis. Results from the Open-label, Multicentre FIRST Study. 2012.